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The fate of cellulose nanocrystal stabilised
emulsions after simulated gastrointestinal
digestion and exposure to intestinal mucosa†
Alan Mackie, *a Simon Gourcy,b Neil Rigby,a,c Jonathan Moffat,d Isabel Caprone
and Balazs Bajka c,f
It is well recognised that the average UK diet does not contain sufficient fibre. However, the introduction
of fibre is often at the detriment of the organoleptic properties of a food. In this study on the gastrointesti-
nal fate of nanoparticles, we have used cellulose nano-crystals (CNCs) as Pickering stabilising agents in oil
in water emulsions. These emulsions were found to be highly stable against coalescence. The CNC and
control emulsions were then exposed to simulated upper gastrointestinal tract digestion and the results
compared to those obtained from a conventional protein stabilised emulsion. Finally the digested emul-
sions were exposed to murine intestinal mucosa and lipid and bile absorption was monitored.
Importantly, the results show that the CNCs were entrapped in the intestinal mucus layer and failed to
reach the underlying epithelium. This entrapment may also have led to the reduced absorption of satu-
rated lipids from the CNC stabilised emulsion versus the control emulsion. The results show the potential
of CNCs as a safe and effective emulsifier.
Introduction
There has been much debate recently about the use of nano-
particles in food.1 The standard definition of a nanoparticle is
an artificially produced particle that is less than 100 nm in any
one dimension. By this definition many food materials already
contain nanoparticles.2 Indeed a number of researchers have
been active in developing nanoscale systems for the enhanced
delivery of bioactives.3–5 Despite this activity there are still some
concerns about the safety of nanoscale structures and un-
certainty about their fate once consumed.6 The gastrointestinal
tract is covered by a protective layer of mucus, a complex
network of highly branched glycoproteins and other macro-
molecules such as DNA. The importance of this mucosal layer as
a barrier to nanoparticle uptake has been demonstrated pre-
viously.7 Absorption of particulate material from the small intes-
tine occurs primarily via transcytosis in the M-cells of the Peyer’s
Patches in the gut-associated lymphoid tissue (GALT), and has
been described for particles in the range 20–500 nm. Absorption
occurs to a lesser extent in enterocytes through clathrin- or
caveolin-mediated endocytosis, pinocytosis and phagocytosis.8
The use of particles to stabilise emulsion droplets has been
known for a long time and was initially described by
Pickering.9 As a result, such colloidal systems have become
known as Pickering emulsions. They have a number of advan-
tages over conventional emulsions associated with high stabi-
lity against coalescence. This is in part because of the high
energy associated with displacing the particles from the inter-
face.10 For large particles, the energy may be of the order of
1000 kT depending on the conditions. This is in contrast small
molecule surfactants where the energy required may only be a
few kT. In addition to the high energy required to remove
them from the interface, the surface properties of the particles
can dictate the type of emulsion formed. Thus, for largely
hydrophilic particles where the contact angle (θ) at the inter-
face is small (θ < 90°) the particles drive the formation of oil in
water emulsions. The large thickness of the particle coating
then provides robust steric stabilisation against coalescence.
In the food arena there are also a number of Pickering stabil-
ised emulsion and foam examples where the particles may be
fat crystals or protein aggregates.2 In each case, the properties
of the particles determine the properties of the colloid.
Cellulose nanocrystals (CNCs) have been studied since the
1950s but have recently regained interest as a Pickering stabi-
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lising agent.11 Cellulose is very widely available from many
different sources and can be milled or otherwise processed
into nanoparticles with relative ease. The use of rods as
Pickering agents has been studied theoretically,12 showing the
importance of the aspect ratio of the rods and the size of the
emulsion droplets in the precise form of the 2-D structures
formed by the rods. This has implications for tuneable delivery
systems. Indeed, there are many examples in the literature of
CNCs used to stabilise emulsions.13,14
Although colloidal systems are widely used in the food
industry because of their extremely acceptable organoleptic
properties, they have also been associated with highly pro-
cessed food. This represents a challenge due to the effective-
ness of such multi-phase systems ability deliver nutrients to
the body. As a result, there is now interest in assessing ways of
making such systems healthier, such as the addition of dietary
fibre. Soluble fibres are normally considered the most effective
as they can delay nutrient absorption through a number of
different mechanisms. However, because of the complex
nature of the digestive process, there are several other systems
that have potential. For example, the use of dietary fibre is one
tool that can be used to lower risk factors for cardiovascular
disease and type 2 diabetes mellitus.15 Several studies have
shown efficacy for a range of different dietary fibres. For
example, the cereal dietary fibre β-glucan has been shown to
lower cholesterol. Although the precise mechanism is not
known, it is thought to involve the sequestering of bile acids,
probably through entrapment of mixed micelles.
The aim of this study was to determine the fate of cellulose
nanoparticles in the upper GI tract. For this purpose we
formed cellulose nano-crystal (CNC) stabilised Pickering emul-
sions and exposed them to simulated upper GI tract digestion.
This was followed by exposure to murine intestinal tissue
where the absorption of both free fatty acids and bile acids
was determined. Using this approach, we aimed to assess the
fate of the CNCs following ingestion and measure the effect of
the cellulose on the absorption of bile and lipid.
Experimental
Materials and methods
The CNCs were kindly provided by Dr Isabel Capron. Their
method of production has been well described previously.16
The stock solution of CNCs was 5 mg mL−1 in water. The
CNCs carry a charge density around 0.2 e nm−2 determined by
titration. The mean size of the CNCs was determined using a
number of different methods. Firstly, the mean (z-average) size
given by dynamic light scattering (DLS) was 102 nm and was
determined using a Malvern Zetasizer Nano-ZS (Malvern
Instruments, UK). In addition, atomic force microscopy (AFM)
was used to determine the size and shape of the CNCs and a
typical image is shown in Fig. 1. Analysis of this and similar
images yielded a value of 133 ± 54 nm for the length, 28.9 ±
7.6 nm for the average width and 6–10 nm for the thickness of
the rods.
Emulsion formation
An emulsion was made comprising 10% sunflower oil and
90% 50 mM NaCl containing 1 mg ml−1 of CNCs. 1 mL of this
mixture was then emulsified using a sonicator with a 3 mm
probe tip set to 20% amplitude and a 90% duty cycle for 4 one
second pulses. The emulsion was then immediately cooled to
4 °C. The emulsion was found to be highly stable with a
means size D(3,2) of 4.0 ± 1.3 µm. The emulsion droplet size
distribution was determined using a LS-230 particle sizer
(Beckman Coulter Ltd, High Wycombe, UK). For the digestion
experiments, 5 mL of emulsion was produced in the same way.
A control emulsion using 3.0 mg mL−1 sodium caseinate solu-
tion in 150 mM NaCl at pH 6.5 was prepared under the same
conditions to serve as a control. The size distribution of this
emulsion was found to be monomodal, with a D(3,2) of 3.0 ±
0.07 µm.
Simulated digestion
The CNC and control emulsions were digested using the
InfoGest method described by Minekus et al.17 Briefly, this
involved a 2 min oral digestion, then 120 min gastric digestion
followed by 120 min of small intestinal digestion.
Atomic force microscopy
The CNCs were prepared for atomic force microscopy (AFM) by
placing a drop of 0.5 mg mL−1 CNC solution on a piece of
freshly cleaved mica. The drop was left for five minutes before
the surface was rinsed with distilled water. Atomic force
microscopy measurements were carried out on the Cypher S
(Oxford Instruments Asylum Research, Santa Barbara, USA) in
amplitude modulated ac mode (commonly known as tapping
mode). The probe used was an AC160TS cantilever from
Olympus, Japan.
Confocal microscopy
The CNC stabilised Pickering emulsions were imaged follow-
ing production, post gastric and post duodenal stages of diges-
tion. Briefly 100 μL sample was incubated with 4 μM Nile Red
to stain the lipid and 100 μM Calcofluor to stain the CNC’s
(Sigma-Aldrich, Poole, UK) for 30 min. 10 μL of the stained
samples were transferred to slides, cover-slipped and sealed.
Samples were imaged using a Leica SP5 II with Calcofluor exci-
Fig. 1 An AFM measurement, topography (left) and phase (right), of
typical CNC’s deposited from aqueous solution onto mica and imaged
under air.
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tation at 405 nm and emission between 415–470 nm and Nile
red excitation at 488 nm and emission between 550–640 nm.
Formalin fixed tissue sampled from the Ussing chamber
samples were embedded in paraffin and 4 μm sections were
cut onto poly-L-lysine coated slides. Sections were incubated
with Oregon green-conjugated wheat germ agglutinin (10 μg
mL−1) and ToPro-3 (10 μM) for 30 min to stain for mucins/cell
membrane glycoproteins and cell nuclei respectively. Samples
were then washed in PBS + 0.01% Tween 60, followed by
10 min incubation in Calcofluor (20 μg ml−1) to stain the
CNC’s. Slides were mounted using Fluoroshield media (Sigma,
Poole, UK) Samples were imaged using a Leica SP5 II with
Calcofluor excitation at 405 nm and emission between
415–470 nm, wheat germ agglutinin (Thermo-Fisher Scientific)
excitation at 488 nm and emission between 500–550 nm and
ToPro-3 (Thermo-Fisher Scientific) excitation at 633 nm and
emission between 640–750 nm. Micrographs and 3D render-
ings were compiled using ImagePro-plus v7.1 or Fiji (ImageJ
v1.51 g).
Cryo-scanning electron microscopy
Scanning electron microscopy (SEM) was carried out using a
Zeiss Supra 55 VP FEG SEM, fitted with a Deben CoolStage
and attached to a Gatan Alto 2500 cryo system. A small drop of
emulsion was pipetted into a brass rivet, which had been
screwed into a sample holder connected to the transfer rod.
The sample holder was immediately plunge frozen into liquid
nitrogen before being loaded into the cryo preparation
chamber of the SEM. The top of the emulsion drop was frac-
tured followed by a short sublimation to remove surface frost.
The sample was platinum coated inside the preparation
chamber and then transferred onto the cooled stage inside the
microscope for imaging.
Animals
Intestinal samples from C57Bl/6 mice were collected following
Schedule One approved euthanasia. All procedures were con-
ducted in accordance with and approval of the University of
East Anglia Animal Ethics Committees and covered by the
appropriate licences under the UK Home Office Animal
Procedures Act, 1986.
Mucosal transport studies
10 cm sections of distal small intestine were flushed and col-
lected into ice cold Ringer’s solution (120 mM NaCl, 3 mM
KCl, 0.5 mM MgCl, 1.25 mM CaCl and 23 mM NaHCO3 at pH
7.4) containing 10 mM Glucose. The most distal 1 cm was dis-
carded to avoid the lymphoid follicle, the remaining tissue was
cut into 1.5 cm sections and the serosa and muscularis layers
were stripped off using fine forceps. Samples were mounted in
low volume Ussing chambers (Physiologic Instruments, San
Diego, USA) using P2404 slider inserts (exposed tissue area =
0.25 cm2). Both apical and basolateral compartments were
filled with 1 mL Ringer’s solution containing 10 mM Glucose
in the basolateral solution and osmotically balanced with
10 mM mannitol in the apical solution. Samples were main-
tained at 37 °C and buffers were continually oxygenated and
circulated using carbogen (5% CO2/95% O2). Open circuit
potential difference (PD) was monitored continuously using a
DVC1000 amplified (World Precision Instruments, New Haven,
USA) and Ag–AgCl electrodes and 150 mM NaCl salt bridges.
At 10 min intervals, a short circuit current (Isc) was applied to
zero the PD. These data were collected using Spike2 v8.0 soft-
ware (Cambridge Electronic Design, Cambridge UK) and used
to calculate trans-mucosal resistance using Ohm’s law. This
serves as an indicator of barrier integrity throughout the
experimental period. Similarly, following completion of the
experiment, 10 µM forskolin and 100 µM 3-isobutyl-1-methyl-
xanthine were added bi-laterally. Tissue segments that
recorded a PD increase <1 mV were excluded from further ana-
lysis.18 Tissue segments were equilibrated for 30 min prior to
commencement of the experimental period. At time 0,
Ringer’s solutions were replaced with 750 µL Ringer’s + 250 µL
digested emulsion on the apical side (+10 mM mannitol). On
the basolateral side, the buffer was replaced with 750 µL
Ringers + 250 µL simulated intestinal salt solution from the
in vitro digestion protocol (+10 mM glucose) in order to mini-
mise osmotic stress. Samples (100 µL) of the apical and baso-
lateral solutions were collected at 0, 30, 60 and 90 min for
determination of bile acid concentrations and the final buffer
solutions were collected for assessment of free fatty acid trans-
port. Tissue segments were collected for morphometric
analysis.
Bile acid analysis
The concentration of total bile acids in intestinal mucus
samples was performed using the bile acids (enzymatic
cycling) test kit (Alpha laboratories, Hampshire, UK) after cen-
trifugation (16 000g, 5 min, 1 °C) and analysed as per the kit
manufacturers protocol except the volumes of sample and
reagents were reduced to perform the assay in a micro titre
plate format. Mucus was mixed with four volumes of PBS
then centrifuged (16 000g, 30 min, 1 °C). The absorbance was
measured at 405 nm using a Bio-Rad Benchmark Plus microti-
tre plate spectrometer (Bio-Rad, Hertfordshire, UK) operated in
the kinetic mode.
Fatty acid analysis
Samples of digesta (0.5 ml) were evaporated to dryness in a
Genevak EZ2 mk 2 evaporator (Genevac, UK) at 40 °C before
being extracted with 0.5 ml of chloroform containing a
mixture of internal standards comprising free fatty acid, mono-
glyceride, diglyceride and triglyceride (FFA heptadecanoic
acid, MG monotridecanoin, DG dinonadecanoin, TG tripenta-
decanoin, (Nu-Chek Prep, USA).
All solid phase extraction steps were performed with flow
under gravity except activation and brief drying steps. The
chloroform extract was applied to a Bond Elut solid phase
extraction cartridge (amino propyl, 500 mg, Agilent UK)
immediately previously activated with 5 ml of hexane and very
briefly dried under vacuum before sample application. The
cartridge was eluted with 2 × 1 mL of chloroform : isopropanol
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(2 : 1 v/v) under gravity using the mixture to rinse out the
sample tube and to wash the walls of the SPE cartridge to
ensure complete loading of the sample. The column was
eluted with a further 2 mL of chloroform : isopropanol (2 : 1
v/v), these fractions were combined and contained the neutral
lipids. The cartridge was then eluted with 4 mL of chloroform :
methanol : acetic acid (100 : 2 : 2 v/v), this fraction contained
the free fatty acids. The solution of neutral lipids was evapor-
ated to dryness at 40 °C (Genevac) and dissolved in 0.5 ml of
hexane while warming at 40–55 °C in a water bath to ensure
complete dissolution of any lipid crystals formed during the
evaporation. The mixture was applied to a second amino
propyl cartridge activated as before. A further 0.5 mL of hexane
was used to dissolve any remaining lipid and wash the walls of
the SPE cartridge to ensure complete loading before it was
developed with a further 3.0 mL of hexane followed by 4.0 mL
of hexane : dichloromethane : chloroform (88 : 10 : 2 v/v), these
extracts were combined and contained the triglyceride com-
ponents. The cartridge was washed with 4.0 mL of hexane :
ethyl acetate (95 : 5 v/v) followed by 4.0 mL of hexane : ethyl
acetate (85 : 15 v/v) and the washings discarded. The cartridge
was eluted with 4.0 mL of hexane : ethyl acetate (20 : 80 v/v),
this fraction contained the diglyceride components. The
monoglyceride components were then eluted with 4.0 mL of
chloroform :methanol (2 : 1 v/v). After evaporation to dryness
at 40 °C (Genevac), the lipid fractions were dissolved in 0.5 ml
of toluene (containing 0.1 mg ml−1 butylated hydroxytoluene,
Sigma) in screw-capped glass tubes equipped with Teflon lined
caps. Methanol (1.0 ml containing 2% sulphuric acid (Sigma))
was added and the tubes were flushed with nitrogen gas
before being incubated overnight at 50 °C in a shaking incuba-
tor at 150 rpm (Incu-Shake Max, SciQuip, UK). Following
cooling the solution was neutralised by the addition of 1.0 ml
of 0.25 M potassium bicarbonate, 0.5 M potassium carbonate
solution and mixed for 30 seconds. The mixture was extracted
with 1.0 ml of hexane and following centrifugation (100g, one
minute) the supernatant was collected and evaporated to
dryness before being redissolved in 100 µl hexane and trans-
ferred to a vial for subsequent analysis.
FAMES were analysed on a Varian CP 3800 GC equipped
with a split-splitless injector and a Saturn 2000 single quad
MS detector (Agilent, UK) fitted with a 100 m SP2560 column,
0.25 mm ID, 0.2 µm film thickness (Sigma, UK). 1.0 µL of
sample was injected, the injector was held at 240 °C, splitless
for 1.5 minutes then split at 50 : 1 for 4.5 minutes before the
split was reduced to 10 : 1 for the remainder of the separation.
The column oven was held at 50 °C for 2 minutes before
ramping to 150 °C at 100 °C per minute, held for one minute,
ramped to 240 °C at 4 °C per minute before being held at this
temperature for the remainder of the separation. Response
factors were determined by analysing a gravimetric FAME stan-
dard (Supelco 37 Food FAME Mix (Sigma)).
Statistics
Statistical analysis was performed using Graphpad Prism
version 5.0 computer software (http://www.graghpad.com).
Comparisons between two groups were made using a student’s
t-test and three groups (and their interactions) were evaluated
using two-way ANOVAs and significance (P < 0.05) determined
multiple comparison tests.
Results
The aim of this study was to determine the fate of cellulose
nanocrystals when used as Pickering stabilisers for a triglycer-
ide emulsion and then after simulated oral consumption.
With this aim in mind an emulsion was produced using soni-
cation as described above. The size distribution of the emul-
sion is given in Fig. 2A. It is clear from the bimodal nature of
the distribution, that the initial emulsion was slightly floccu-
lated. However, the emulsion became well dispersed upon the
addition of bile as shown by the narrow size distribution in
Fig. 2A. The mean size of the emulsion was found to be
unchanged after 3 days, demonstrating that the CNCs had
formed an effective steric barrier on the emulsion droplets.
Distribution of the CNCs on the emulsion surface was assessed
microscopically. Confocal images, showing cross-sections of
the stabilised emulsion shows a complete, but non-uniform
distribution of CNCs on the surface (Fig. 2B), additionally,
areas with higher CNC concentration appear to provide points
for flocculation. Further assessment of the surface distribution
was carried out using freeze fracture cryo-SEM (Fig. 2C) con-
firming the results seen by confocal microscopy, while the
entire surface of the emulsion droplet is coated in CNCs, areas
with higher density were observed. Additionally, the size and
structure of the CNCs observed correlate with the data
obtained by atomic force microscopy (Fig. 1).
Having produced a stable emulsion, it was then exposed to
simulated gastrointestinal digestion based on the standard
Infogest conditions.17 The initial stage of digestion was
2 hours of gastric simulation at pH 3. Under these conditions,
the CNC emulsion was less flocculated than the initial emul-
sion as shown in Fig. 3A and droplets size was unchanged.
The confocal micrograph in Fig. 3B shows the emulsion dro-
plets surrounded by a heterogeneous layer of CNCs demon-
strating the propensity of the CNCs to aggregate, even in the
surface layer of the droplets. In contrast, there was a signifi-
cant, and rapid decrease in droplet size once the emulsion was
passed into the intestinal phase of digestion. Prolonged
Fig. 2 (A) The surface area weighted size distribution of the CNC stabil-
ised emulsion in the absence and presence of bile. (B) A confocal image
of the CNC stabilised emulsion showing the lipid droplets in red sur-
rounded by a layer of CNCs in blue. (C) A cryo-SEM image of the stabil-
ised emulsion showing the CNCs on the surface of a lipid droplet.
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exposure to the intestinal conditions digested essentially all
the triglyceride emulsion leaving only particles of a few
hundred nanometres. This is confirmed from the image in
Fig. 3C, showing that the lipid droplets were no longer sur-
rounded by a shell of CNCs but were instead surrounded by a
variety of self-assembled structures formed from lipid hydro-
lysis products, primarily fatty acids and monoglycerides. The
CNCs that are visible in the image are clearly in aggregates
that are no longer associated with the lipid droplets. Indeed,
some of the CNCs associated with the 10 µm droplet in the
bottom right of the image can be seen in the process of being
removed from the droplet interface as a coherent sheet. The
image also highlights the propensity of the lipid hydrolysis
products to form lamella structures.
In order to determine the fate of the CNCs once exposed to
the intestinal mucosa, Ussing chambers containing murine
intestinal mucosa had the apical chamber filled with a four-
fold diluted sample of control or CNC emulsion following
in vitro digestion. The images in Fig. 4 show the intestinal
mucosa after 90 minutes exposure to CNCs. It is clear that the
CNCs were trapped in the mucus layer, as there is no evidence
of calcofluor staining in the mucosal tissue (Fig. 4A). Indeed,
at higher magnification, there is little evidence that the CNCs
were able to penetrate the mucus layer to any extent (Fig. 4B).
In addition to determining the final location of the CNCs,
the impact of the CNCs on the transport and absorption of
bile acids (BA) and free fatty acids (FFAs) was also measured.
This was achieved by measuring concentrations in both the
apical and basolateral chambers as a function of time follow-
ing in vitro digestion of the control and CNC stabilised emul-
sions. Epithelial barrier integrity was maintained throughout
the experimental period as demonstrated trans-mucosal resis-
tance (Fig. 5A) and no significant differences were observed
between control and CNC groups. Fig. 5B shows bile absorp-
tion by ileal segments as the decrease in concentration over
the length of the experiment. By 30 min, significantly less bile
acid had been absorbed in samples containing the digested
CNC stabilised emulsion compared to the control. No differ-
ence was observed in the basolateral buffer samples. This is
most likely because values were at or below the limit of detec-
tion (data not shown) and any bile remaining in the tissue
samples was not measured.
The amount of individual fatty acids present as a pro-
portion of the total fatty acid pool is outlined in Table 1.
Overall, there was no significant difference in the total FFAs
between the control and CNC stabilised emulsions even
though a trend toward lower absorption was observed in
Fig. 6B. Individually, Linoleic acid (C18:2) showed a significant
proportion remaining on the apical side of the tissue after
90 minutes with the control being more than 10% lower.
While this fatty acid made up the highest proportion of the
total FFA profile, little was absorbed across the intestinal
barrier and although there were differences in the basolateral
proportions observed, these were not significant due to the low
concentrations involved. However, significantly less stearic
acid (C18:0) and eicosanoic acid (C20:0) were absorbed from
the CNC emulsion following the 90 min incubation. This
result suggests that CNC stabilisation of the emulsions may
Fig. 3 The surface area weighted size distribution of the CNC emulsion
through digestion. The confocal images are of samples taken after the
gastric (B) and intestinal (C) phases of digestion.
Fig. 5 (A) Trans-mucosal resistance, (B) bile acid absorption in the
distal ileum as measured by the decrease in apical bile concentration.
Data for control (○) and CNCs (●) are expressed as a percentage change
from baseline. N = 4–5 per group (***p < 0.001, by 2-way Annova).
Fig. 4 Confocal micrographs of intestinal mucosal segments following
120 min incubation in Ussing chambers. (A) 20× magnification, and (B)
63× magnification. Samples were stained with Calcofluor for CNCs
(blue), wheatgerm agglutinin for mucins (green) and ToPro-3 for DNA
(red).
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differentially affect absorption of saturated (Fig. 6A) and unsa-
turated (Fig. 6B) FFAs with inhibition of the absorption of
saturated fatty acids.
Discussion
Initial characterisation of the CNCs using DLS and AFM has
provided detail of their structure. This is consistent with pre-
vious electron microscopy studies,19,20 and values compare
well with previous measurements from small angle neutron
scattering in suspension that gave average dimensions of 195 ±
35 nm in length, 22 ± 3 nm in width, and 6 ± 0.2 nm in thick-
ness.21 Additionally, this study builds on previous descriptions
of the CNCs at the interface of a Pickering stabilised emulsion
and the first in a food-ready system. The confocal imaging
(including 3D, z-stack reconstructions, see ESI†) and the cryo-
SEM demonstrate similar structure to those observed pre-
viously using styrene-in-water emulsions16 with uneven distri-
bution on the oil-droplets surface. While it is unclear if the
CNC aggregation occurred prior to, or during adhesion to the
oil-droplets, it resulted in flocculation of the initial stabilised
emulsion. This was most likely driven by a bridging
mechanism.10
The surface area weighted size distribution and confocal
imaging demonstrates that the CNC stabilised emulsions
resist digestion through the gastric phase. In contrast to more
conventional protein stabilised emulsions,22 CNC stabilised
emulsions showed reduced flocculation in gastric conditions
although this is unlikely due to changes in the electrostatic
interactions as the charge is unlikely to have changed.23
However, the shift in particle size following the addition of
pancreatin (which includes lipase) in the intestinal phase
suggests the lipid within the emulsion was readily available for
hydrolysis. Thus, there were some areas of the lipid droplets
that were not protected by a CNC coating, allowing bile and
more importantly, the lipase/co-lipase complex to access the
oil/water interface. This is consistent with the 3D confocal
reconstructions demonstrating areas of no CNC coverage and
previous studies that suggest 40% coverage with un-sulphated
CNCs.16 However, it is at odds with previous studies using
CNCs and whey protein that were able to retard lipolysis.24
Indeed, in this case, significant digestion has occurred by
15 min and at 120 min, virtually all triglycerides had been
hydrolysed with the mean particle size dropping to 100 nm,
likely comprising CNC aggregates and larger self-assembled
structures (the primary peak in Fig. 3A), and mixed micelles.
Both the size distribution and the micrographs have shown
that the CNCs are likely to form discrete aggregates in the
intestinal lumen that not associated with lipid droplets. These
data suggest that CNCs are an effective material for stabilising
lipid emulsions, allowing survival in a gastric environment but
disassembly under small intestinal conditions. Thus allowing
effective delivery of lipid and lipid soluble compounds.
Subsequently, the fate of the CNCs in the gut lumen is as
aggregated clusters of crystals with a size of circa 100 nm.
In order to interact with the gut wall, particles must pass
through the intestinal mucus layer. Murine tissue explants
were used to ascertain the fate of the CNCs after in vitro diges-
tion and their influence on lipid and bile absorption in the
small intestine. Ussing-type perfusion chambers were used to
determine permeability across the intact intestinal mucosal
barrier, including the mucus layer. This study provides the
first clear evidence that CNCs become trapped in the intestinal
mucus layer post-digestion and are unable to reach the under-
lying enterocytes. Thus the proposed routes of absorption of
the CNCs envisaged by others,25 such as through M-cells,
through enterocytes by passive diffusion, through enterocytes
Table 1 Absorption of free fatty acids across murine distal ileum in Ussing chambers. Data presented as a percentage of the total free fatty acid





p-ValueMean SEM Mean SEM Mean SEM Mean SEM
C16:0 6.856 0.268 6.694 0.229 0.328 1.475 0.275 0.884 0.186 0.11
C16:1 0.504 0.072 0.591 0.176 0.346 0.182 0.116 0.281 0.134 0.608
C18:0 4.152 0.185 4.048 0.145 0.332 0.879 0.158 0.411 0.069 0.022
C18:1 30.89 1.351 29.21 0.983 0.169 7.924 0.729 6.224 1.616 0.41
C18:2 44.69 1.062 50.02 1.753 0.023 0.931 0.285 0.769 0.361 0.667
C20:0 0.334 0.088 0.258 0.067 0.253 0.966 0.061 0.435 0.128 0.011
Total 87.426 1.219 90.821 1.917 0.105 12.357 1.219 9.004 1.917 0.211
Fig. 6 (A) Saturated and (B) unsaturated free fatty acid concentrations
as a percentage of total free fatty acids in the apical and basolateral
media of distal ileal explants after 90 min. Data for control (○) and CNCs
(●) are expressed as a percentage change from baseline. N = 4–5 per
group (***p < 0.05, by 2-way Annova).
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by transcytosis or through the paracellular route, seem not to
be realised.
Recent evidence has demonstrated that dietary polysacchar-
ides can alter cholesterol and lipid homeostasis, potentially
through the sequestration of bile acids, inhibiting their re-
cycling and decreasing permeability of the mucus layer,
slowing diffusion of digestion products self-assembled into
mixed micelles. The cholesterol-lowering potential of dietary
fibre is currently thought to involve the sequestering of bile
acids, either through a direct interaction or as a result of
increased luminal viscosity and entrapment of mixed micelles.
Recent evidence demonstrates inhibition of fat digestion
in vitro,26 potentially through interactions between water-
soluble dietary fibre and pancreatic lipase. While soluble cell-
ulose esters have demonstrated significant bile acid binding
in vitro,27 less is known about the functional properties of the
insoluble fibres, such as cellulose, within the gut environment.
While this study demonstrates a decrease in bile absorption in
tissue explants from the murine ileum, the mechanism and
potential interaction with intestinal mucus remain unclear.
The hydrolysis of dietary fat is extremely efficient in the
mammalian small intestine, but the range of digestion pro-
ducts is extremely diverse.28 However, all of the products
readily self-assemble into structures of different size and only
the smallest can diffuse through the mucus layer and be
absorbed. While the mean micelle radius of sunflower oil fol-
lowing in vitro digestion is 3.05 nm ± 0.05 nm (ref. 29) they can
also vary in size depending on the concentrations of saturated
and unsaturated free fatty acids, bile salts, cholesterol, etc.
Indeed, decreasing bile concentrations significantly increases
micelle size30 and this will affect diffusion through the mucus
layer.
Although saturated fatty acids only account for approxi-
mately 11% of the total fatty acid pool in this study, the data
provides the first evidence that an insoluble dietary fibre may
differentially regulate absorption of saturated and unsaturated
free fatty acids in the small intestine, although further studies
will be required to validate this finding. Early studies investi-
gating lipid digestion demonstrated slower absorption of satu-
rated compared to unsaturated fatty acids.31 The selective
absorption may relate to the differences observed in bile acid
uptake and/or the size of the mixed micelles formed during
digestion through altered micelle packaging. Alternatively,
several studies have demonstrated interactions between several
types of dietary fibre and the mucus layer.32–36 It is proposed
that the fibre could block the pores in the mucus network
altering mucus permeability and reducing lipid micelle
diffusion. The micrographs (Fig. 4) demonstrate that CNCs
become trapped by the mucus layer and this may reduce its
permeability to mixed micelles thereby reducing diffusion in a
similar way to soluble fibres.37,38 If so, the fibre decreases the
effective pore size of the mucus and limits diffusion of particu-
late species. These include mixed micelles, which are self-
assembled structures of ≥10 nm and so are most likely to be
affected. The mass transfer of other macronutrients such as
peptides and reducing sugars are less likely to be influenced.
Conclusions
The use of insoluble fibres, such a cellulose nanocrystal, may
have multiple benefits over emulsifiers currently used in the
food and pharmaceutical industries. The observed stability,
low flocculation and coalescence in simulated gastric con-
ditions will impact rates of lipolysis in the small intestine,
potentially providing an effective delivery vehicle for lipophilic
drugs. Importantly, this study demonstrated that the intestinal
mucus layer prevents the CNCs from reaching the epithelium
and that may modulate lipid absorption and bile recycling that
could potentially lower plasma cholesterol. Thus, CNCs rep-
resent a safe and effective emulsifier. Determining the extent
of these benefits would require further work required.
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